NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Health Business Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Algonomics



Algonomics Receives EUR 0.9 Million 1.2 M$ Research Funding from the Flemish Government



May 15th, 2009

Today, Algonomics announced it receives EUR 0.9 million (approx. USD 1.2 million) research funding from the Flemish Institute for the Promotion of Innovation by Science and Technology (IWT). Under the research program, Algonomics will collaborate with the research groups of Dr. Soren Buus (University of Copenhagen, DK) and Dr. Roberto Mallone (Inserm, FR). This 2 year funding will drive further development of Algonomics’ Epibase® platform for predictive immunogenicity of biotherapeutics. Epibase® is broadly used in the biopharma industry to estimate the relative risk to observe an immune response against protein therapeutics.

Dr. Soren Buus, head of the laboratory of...


Source: Health Business Week (2009-05-15)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login